Psychoactive Drugs Are Having a Moment. The FDA Will Soon Weigh In. By Dawn Megli MAY 29, 2024

https://kffhealthnews.org/news/article/psychoactive-drugs-popularity-fda-regulation-studies-mdma/?utm_campaign=KHN%20-%20Weekly%20Edition&utm_medium=email&_hsenc=p2ANqtz--KaN8mcknk9_8dw2iVwInPR9AZjK3kvdw5RUpQOiXNNzTS3Sypng86Ux2qqF_tZsK8plsoRKg1Yw9-NdRWBoz1Hc3UeQ&_hsmi=309622936&utm_content=309622936&utm_source=hs_email Psychoactive Drugs Are Having a Moment. The FDA Will Soon Weigh In. By Dawn Megli Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.